NCT05559541 2025-02-19Study of AK119 Combined With AK104 in Patients With Advanced Solid TumorsAkesoPhase 1/2 Terminated33 enrolled
NCT06524804 2024-12-18A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid TumorsChengdu Baiyu Pharmaceutical Co., Ltd.Phase 1/2 Terminated60 enrolled